Digital twins moving to operations
Teams are reframing digital twins as focused decision‑support layers rather than full plant simulations, built from contextualised process, equipment and quality data for specific tasks like harvest timing or deviation prediction. Industry posts show platforms already simulating molecular hypotheses and manufacturing scenarios pre‑wet lab, highlighting use‑case‑first twin deployments rather than enterprise‑wide models. (x.com)
A digital twin is turning into a working control-room tool, not a giant mirror of an entire factory. Recent pharma and manufacturing papers describe teams building smaller models around one decision at a time, using live process and quality data to guide operations. (ispe.org) In biopharma, that means a software model tied to the real process through process analytical technology, manufacturing execution systems, and other plant data feeds. A January 2024 Springer chapter said fully integrated twins in biopharma were still rare, even as interest rose around cost, productivity, and quality gains. (link.springer.com) By 2025, the language had shifted toward decision support. An August 2025 manufacturing paper framed digital twins as “decision-making” systems with optional modes, rather than as static replicas built for their own sake. (springer.com) Industry groups are now describing a “federated” approach: multiple twins, each tied to a specific critical business parameter, linked together only where needed. The International Society for Pharmaceutical Engineering wrote in July and August 2025 that companies can simplify complex process flows into modular building blocks instead of chasing one all-encompassing model. (ispe.org) That narrower setup fits how plants actually run. Operators usually need a call on the next batch, the next deviation, or the next maintenance window, not a full physics model of every pump, tank, and assay at once. (databricks.com) The same pattern is showing up before manufacturing starts. Turbine said on April 24, 2025 that it opened a “virtual lab” built on cell simulations so scientists could design and iterate experiments digitally before running wet-lab work. (turbine.ai) Academic work is pushing in the same direction. A Nature Computational Science paper published December 31, 2025 described MATTERIX, a graphics processing unit-accelerated digital twin for chemistry labs that simulates robots, liquids, heat transfer, and basic reaction kinetics to test automated workflows in silico. (nature.com) Reviews published in 2025 place these examples on a single timeline, from drug discovery through continuous manufacturing. They also list the same obstacles: stitching together data from different systems, keeping models accurate enough to trust, and fitting all of it into regulated production. (pmc.ncbi.nlm.nih.gov) So the current move is less about building a perfect virtual factory than about putting a reliable model beside a real decision. The teams getting there first appear to be the ones starting with one use case, one data pipeline, and one operational question they can validate on the plant floor. (ispe.org)
